Search by Drug Name or NDC
NDC 00024-5151-75 Elitek Details
Elitek
Elitek is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sanofi-Aventis U.S. LLC. The primary component is .
MedlinePlus Drug Summary
Rasburicase injection is used to treat high levels of uric acid (a natural substance that builds up in the blood as tumors break down) in people with certain types of cancer who are being treated with chemotherapy medications. Rasburicase injection is in a class of medications called enzymes. It works by breaking down uric acid so that the body can eliminate it.
Related Packages: 00024-5151-75Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rasburicase Injection
Product Information
| NDC | 00024-5151 |
|---|---|
| Product ID | 0024-5151_619ea95d-54eb-4525-a7fa-7bfccc0cc80d |
| Associated GPIs | 21764065002140 |
| GCN Sequence Number | 050838 |
| GCN Sequence Number Description | rasburicase VIAL 7.5 MG INTRAVEN |
| HIC3 | C7G |
| HIC3 Description | HYPERURICEMIA TX - URATE-OXIDASE ENZYME-TYPE |
| GCN | 18147 |
| HICL Sequence Number | 022109 |
| HICL Sequence Number Description | RASBURICASE |
| Brand/Generic | Brand |
| Proprietary Name | Elitek |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | rasburicase |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | KIT |
| Route | n/a |
| Active Ingredient Strength | n/a |
| Active Ingredient Units | n/a |
| Substance Name | n/a |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103946 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00024-5151-75 (00024515175)
| NDC Package Code | 0024-5151-75 |
|---|---|
| Billing NDC | 00024515175 |
| Package | 1 KIT in 1 CARTON (0024-5151-75) * 5 mL in 1 VIAL, SINGLE-USE (0024-5155-74) * 5 mL in 1 AMPULE (0024-5153-74) |
| Marketing Start Date | 2006-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |